Compounds > (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride
Page last updated: 2024-11-08

(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride and Clostridium tetani Infection

(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride has been researched along with Clostridium tetani Infection in 1 studies

(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride: A drug that selectively activates certain subclasses of muscarinic receptors and also activates postganglionic nicotinic receptors. It is commonly used experimentally to distinguish muscarinic receptor subtypes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castellão-Santana, LM1
Yumi Abiko, P1
Ambiel, CR1
Peixoto, AR1
Noronha-Matos, JB1
Correia-de-Sá, P1
Alves-Do-Prado, W1

Other Studies

1 other study available for (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride and Clostridium tetani Infection

ArticleYear
Tetanic Facilitation of Neuromuscular Transmission by Adenosine A2A and Muscarinic M1 Receptors is Dependent on the Uptake of Choline via High-Affinity Transporters.
    Pharmacology, 2019, Volume: 103, Issue:1-2

    Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Adenosine; Animals; Colforsin;

2019